During the past decade, Ruijin Hospital, Affiliated to Shanghai Jiaotong University conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ruijin Hospital, Affiliated to Shanghai Jiaotong University" #1 sponsor was "Biotech Pharmaceutical Co., Ltd." with 1 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored, "GeneQuantum Healthcare (Suzhou) Co., Ltd." with 1 trials sponsored, "Shanghai Zhongshan Hospital" with 1 trials sponsored and "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ruijin Hospital, Affiliated to Shanghai Jiaotong University" #1 collaborator was "Fudan University" with 1 trials as a collaborator and "NanJing PLA 81 Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ruijin Hospital, Affiliated to Shanghai Jiaotong University" are "Acute Kidney Injury" (1 trials), "Ascites Hepatic" (1 trials), "Chronic Hepatitis B" (1 trials), "HER2-Positive Advanced Solid Tumor" (1 trials) and "HER2-Positive Salivary Gland Carcinomas" (1 trials). Many other conditions were trialed in "Ruijin Hospital, Affiliated to Shanghai Jiaotong University" in a lesser frequency.

Most popular intervention types in "Ruijin Hospital, Affiliated to Shanghai Jiaotong University" are "Drug" (4 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baraclude tablets" (1 trials), "Blank maleate entecavir tablets" (1 trials), "Entecavir maleate tablets" (1 trials), "GQ1001" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ruijin Hospital, Affiliated to Shanghai Jiaotong University" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Ruijin Hospital, Affiliated to Shanghai Jiaotong University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ruijin Hospital, Affiliated to Shanghai Jiaotong University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ruijin Hospital, Affiliated to Shanghai Jiaotong University, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".